Brigitte Devaux

USPTO Granted Patents = 32 (Patent Applications = 18)

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 14)

Average Co-Inventor Count = 8.3

ph-index = 9

Forward Citations = 494(Granted Patents)

Location History:

Redwood City, CA (US) (2003 - 2008)
Palo Alto, CA (US) (2008 - 2024)

Company Filing History:

24 out of 3,681

Bristol-myers Squibb Compnay

Cytomx Therapeutics, Inc.

The Rockefeller University

patents

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

32 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12372536 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof (2025-07-29),

2. 12312403 - Antibodies against TIM3 and uses thereof (2025-05-27),

3. 12129297 - Antibodies against TIM3 and uses thereof (2024-10-29),

4. 12060421 - Antibodies to TIGIT (2024-08-13),

5. 11952427 - Anti-CD40 antibodies and uses thereof (2024-04-09),

6. 11591392 - Antibodies against TIM3 and uses thereof (2023-02-28),

7. 11474112 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof (2022-10-18),

8. 11306149 - Anti-CD40 antibodies and uses thereof (2022-04-19),

9. 11008390 - Antibodies to TIGIT (2021-05-18),

10. 10844130 - Nucleic acids encoding an anti-CD40 antibody (2020-11-24),

11. 10533052 - Antibodies against TIM3 and uses thereof (2020-01-14),

12. 10479838 - Antibodies to CD40 with enhanced agonist activity (2019-11-19),

13. 10196452 - Binding molecules to the human OX40 receptor (2019-02-05),

14. 10189902 - Antibodies to TIGIT (2019-01-29),

15. 10077306 - Antibodies against TIM3 and uses thereof (2018-09-18),

Certainly! Here is the article about inventor Brigitte Devaux:

Title: The Innovation Journey of Brigitte Devaux

Introduction:

Brigitte Devaux, a prolific inventor based in Palo Alto, CA, has made significant contributions to the field of biotechnology with his groundbreaking patents and research initiatives. With 28 patents to his name, Devaux stands out as a leading figure in the realm of therapeutic antibodies and their diverse applications.

Latest Patents:

Among his recent patents is the invention of Anti-CD40 antibodies and their uses in the treatment of cancer and chronic infections. These agonistic antibodies exhibit enhanced yield and reduced aggregation, offering promising avenues for targeted therapy. Additionally, Devaux's work on antibodies against TIM3 showcases their potential in combating cancer and other debilitating conditions, further solidifying his reputation as an innovative thinker in the field.

Career Highlights:

Having worked with esteemed organizations such as Bristol-Myers Squibb Company and Pfizer Corporation, Devaux has honed his skills and expertise in developing cutting-edge solutions for complex medical challenges. His commitment to advancing healthcare through research and innovation has garnered acclaim within the industry.

Collaborations:

Throughout his career, Devaux has collaborated with notable peers such as Peter Brams and Haichun Huang, fostering a culture of interdisciplinary exchange and collective learning. These collaborative efforts have not only enriched his own work but have also paved the way for transformative discoveries in the field of biotechnology.

Conclusion:

In conclusion, Brigitte Devaux's remarkable journey as an inventor underscores his unwavering dedication to technological advancement and healthcare innovation. His pioneering work in the development of therapeutic antibodies continues to inspire future generations of inventors and researchers, leaving a lasting impact on the landscape of modern medicine.

This text is generated by artificial intelligence and may not be accurate.